These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models. Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD. J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755 [Abstract] [Full Text] [Related]
11. External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis. Mazya MV, Bovi P, Castillo J, Jatuzis D, Kobayashi A, Wahlgren N, Ahmed N. Stroke; 2013 Jun; 44(6):1595-600. PubMed ID: 23632975 [Abstract] [Full Text] [Related]
12. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA, Starr JA. Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [Abstract] [Full Text] [Related]
13. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ. Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [Abstract] [Full Text] [Related]
14. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D. Cerebrovasc Dis; 2013 Oct; 35(1):45-52. PubMed ID: 23428996 [Abstract] [Full Text] [Related]
16. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register. Keselman B, Cooray C, Vanhooren G, Bassi P, Consoli D, Nichelli P, Peeters A, Sanak D, Zini A, Wahlgren N, Ahmed N, Mazya MV. Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434 [Abstract] [Full Text] [Related]
17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan. Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K. J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092 [Abstract] [Full Text] [Related]
18. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC, Sung SF, Ong CT, Wu CS, Su YH. Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [Abstract] [Full Text] [Related]
19. Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation. Flint AC, Rao VA, Chan SL, Cullen SP, Faigeles BS, Smith WS, Bath PM, Wahlgren N, Ahmed N, Donnan GA, Johnston SC, SITS International and VISTA-plus investigators. Int J Stroke; 2015 Aug; 10(6):815-21. PubMed ID: 26045081 [Abstract] [Full Text] [Related]
20. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke. Al-Khaled M, Matthis C, Eggers J. J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]